Mitoxantrone

CAS No. 65271-80-9

Mitoxantrone( mitozantrone )

Catalog No. M18958 CAS No. 65271-80-9

Mitoxantrone is an anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 48 In Stock
25MG 31 In Stock
50MG 44 In Stock
100MG 60 In Stock
200MG 101 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Mitoxantrone
  • Note
    Research use only, not for human use.
  • Brief Description
    Mitoxantrone is an anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication.
  • Description
    Mitoxantrone is an anthracenedione antibiotic with antineoplastic activity. Mitoxantrone intercalates into and crosslinks DNA, thereby disrupting DNA and RNA replication. This agent also binds to topoisomerase II, resulting in DNA strand breaks and inhibition of DNA repair. Mitoxantrone is less cardiotoxic compared to doxorubicin.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    mitozantrone
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Topo II
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    65271-80-9
  • Formula Weight
    444.48
  • Molecular Formula
    C22H28N4O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 150 mg/mL; 337.47 mM
  • SMILES
    OCCNCCNc1ccc(NCCNCCO)c2c1C(=O)c1c(O)ccc(O)c1C2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Bellosillo B, et al. Br J Haematol, 1998, 100(1), 142-146.
molnova catalog
related products
  • Bispyrazolone

    Bispyrazolone is white or light yellow crystalline powder.

  • RMC-6291

    RMC-6291 is an orally active, covalent inhibitor of KRAS G12C (ON) that forms a tri-complex within tumor cells between KRAS G12C (ON) and cyclophilin A (CypA), thereby preventing KRAS G12C (ON) from signaling via steric blockade of RAS effector binding and eliciting deep and durable suppression of RAS pathway activity in KRAS G12C tumor models .

  • (+)-Puerol B 2-O-glu...

    (+)-Puerol B 2''-O-glucoside is a natural product for research related to life sciences.